JBI-802

N/A

Report date: 2023/01/17 16:09:20
NME

Base Information

Drug NameJBI-802
Drug Alias NameJBI-802
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysine-specific histone demethylase 1 inhibitorsHistone deacetylase 6 inhibitors
TargetsHistone deacetylase 6Lysine-specific histone demethylase 1
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesJubilant Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesThe Christ HospitalJubilant Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A